Skip to content

Prospective Investigation of Robotic Single-port System

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02136121
Enrollment
19
Registered
2014-05-12
Start date
2010-06-30
Completion date
2013-10-31
Last updated
2014-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate and Kidney Cancer

Brief summary

To determine the feasibility of representative urologic procedures as measured by the rate of conversions

Interventions

DEVICEda Vinci Sp Surgical System - Robotic

robotic assisted laparoscopic single-port system

Sponsors

Intuitive Surgical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Prostatectomy: * Patients age 18-75 years * BMI \<=35 kg/m2 * Confirmed localized adenocarcinoma of the prostate * Suitable for minimally invasive prostate cancer surgery Nephrectomy: * Patient age 18-75 years * BMI \<=35 kg/m2 * Kidney disease amenable to nephrectomy or partial nephrectomy * Suitable for minimally invasive kidney surgery

Exclusion criteria

Untreated active infection (includes local kidney infection) * Vulnerable population (ex: prisoners, mentally disabled) * Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions (i.e., cancer) * Anatomy unsuitable for endoscopic visualization or minimally invasive surgery * Patient with second primary cancer * Extensive previous abdominal surgery * Prior radiation treatment for prostate or kidney cancer * Patient with distant metastasis * Complex renal vascular anatomy * Patient with kidney cancer - stage T3 or N+ M+ \*\* * Horseshoe kidney\*\* * Previous ipsilateral kidney surgery \*\*- specific to kidney surgery -

Design outcomes

Primary

MeasureTime frameDescription
To determine the feasibility as measured by the rate of conversionsIntra OperativeRate of Conversion to Open approach

Secondary

MeasureTime frameDescription
Perioperative surgical outcomesFrom admission to discharge from the hospital for the primary procedure typically up to 7 daysPerioperative surgical outcomes length of hospital stay- From admission to discharge from the hospital for the primary procedure
Perioperative Surgical outcomesIntra-operativeRate of Transfusion
Perioperative Surgical Outcomes30 day, 1 year , 2 year and 3 year follow upProcedure specific wound complications , infection
Post-operative - Continence1 year, 2 year and 3 year follow upContinence measured by use of pads
Perioperative Surgical Outcome- potency1 , 2 and 3 year follow upPotency rate administered by International Index of Erectile Function patient questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026